Ruth Coll

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 442 citations · Full text

Medicine, Oncology, Urology +13

Final results of a phase I–II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration

Robert Soler, Lluís Orozco, Ana Munar et al. · The Knee · 2016 · 181 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study

Sergiu Albu, Hatice Kumru, Ruth Coll et al. · Cytotherapy · 2020 · 111 citations

Medicine, Neuroscience, Neurosurgery +16

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft

Cristina Prat‐Vidal, Luciano Rodríguez-Gómez, Miriam Aylagas et al. · EBioMedicine · 2020 · 51 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

A polygenic risk score added to a QRISK®2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting

Ahmet Fuat, Ella Adlen, Mark Monane et al. · European Journal of Preventive Cardiology · 2024 · 44 citations · Full text

Medicine, Cardiology, Family Medicine +17